Abstract
One of the leading causes of mortality worldwide is cardiovascular disease, which is influenced by some variables, including calcium and vitamin D. This study aimed to assess the relationship between Angiopoietin-Like 3 (ANGPTL3) gene polymorphisms with vitamin D and calcium levels in cardiovascular disease (CVD) patients. In this research, 1002 people participated. Participants' anthropometric parameters, and FBG, calcium, and vitamin D were assessed. Blood samples were used to extract DNA. Taqman®-based polymerase chain reaction (PCR) was used to conduct genetic analysis for the rs10789117 and rs17458195. Statistical analysis was applied to determine differences across subgroups and the relationship between polymorphisms and disease. Age, body mass index (BMI), fasting Blood Sugar (FBG), phenylalanine ammonia-lyase (PAL), and smoking history were significantly correlated with CVD. Vitamin D was statistically associated with rs10789117 and rs17458195 in non-CVD individuals. In the moderate group, individuals with the C allele in rs10789117 showed a tenfold increase in vitamin D deficiency compared to those with the A allele. However, in rs11207997, individuals with the T allele had 5 to 6 times higher vitamin D deficiency than those with the C allele in all groups. This research demonstrates the relationship between some ANGPTL3 gene polymorphisms and complement levels in CVD patients. It may be concluded that individuals carrying these variants would likely benefit from using vitamin D and calcium supplements to avoid CVD.
Similar content being viewed by others
References
Adam RC, Mintah IJ, Alexa-Braun CA, Shihanian LM, Lee JS, Banerjee P et al (2020) Angiopoietin-like protein 3 (ANGPTL3) governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance. J Lipid Res 61(9):1271–1286
Aghasizadeh M, Zare-Feyzabadi R, Kazemi T, Avan A, Ferns GA, Esmaily H, et al (2021) A haplotype of the ANGPTL3 gene is associated with CVD risk, diabetes mellitus, hypertension, obesity, metabolic syndrome, and dyslipidemia. Gene 782:145525
Akter R, Afrose A, Sharmin S, Rezwan R, Rahman MR, Neelotpol S (2022) A comprehensive look into the association of vitamin D levels and vitamin D receptor gene polymorphism with obesity in children. Biomed Pharmacother 153:113285
Barati E, Ghazizadeh H, Sadabadi F, Kazemi E, Ferns GA, Avan A et al (2019) Association of the IL6 gene polymorphism with component features of metabolic syndrome in obese subjects. Biochem Genet 57(5):695–708
Barbarawi M, Kheiri B, Zayed Y, Barbarawi O, Dhillon H, Swaid B et al (2019) Vitamin D supplementation and cardiovascular disease risks in more than 83 000 individuals in 21 randomized clinical trials: a meta-analysis. JAMA Cardiol 4(8):765–776
Barchetta I, Cimini FA, Chiappetta C, Bertoccini L, Ceccarelli V, Capoccia D et al (2020) Relationship between hepatic and systemic angiopoietin-like 3, hepatic Vitamin D receptor expression and NAFLD in obesity. Liver Int 40(9):2139–2147
Biterova E, Esmaeeli M, Alanen HI, Saaranen M, Ruddock LW (2018) Structures of Angptl3 and Angptl4, modulators of triglyceride levels and coronary artery disease. Sci Rep 8(1):1–12
Chen M-C, Hsu B-G, Lee C-J, Wang J-H (2020) High-serum angiopoietin-like protein 3 levels associated with cardiovascular outcome in patients with coronary artery disease. Int J Hypertens. https://doi.org/10.1155/2020/2980954
Criqui MH, Denenberg JO, Ix JH, McClelland RL, Wassel CL, Rifkin DE et al (2014) Calcium density of coronary artery plaque and risk of incident cardiovascular events. JAMA 311(3):271–278
Dewey FE, Gusarova V, Dunbar RL, O’Dushlaine C, Schurmann C, Gottesman O et al (2017) Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease. N Engl J Med 377(3):211–221
Dhingra R, Sullivan LM, Fox CS, Wang TJ, D’Agostino RB, Gaziano JM et al (2007) Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 167(9):879–885
Fiaz H, Khan AR, Abbas S, Bilal A, Khan HN, Hussain M et al (2022) Association of vitamin D receptor polymorphisms with cardiometabolic conditions in Pakistani population. Int J Vitamin Nutr Res. https://doi.org/10.1024/0300-9831/a000772
Foley RN, Collins AJ, Ishani A, Kalra PA (2008) Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 156(3):556–563
Fry CM, Sanders TA (2015) Vitamin D and risk of CVD: a review of the evidence. Proceed Nutr Soc 74(3):245–257
Fu Y-S, Wang J-H, Lee C-J, Hsu B-G (2018) Positive correlation of the serum angiopoietin-like protein 3 levels with the aortic augmentation index in patients with coronary artery disease. Ther Clin Risk Manag 14:231
García-Monzón C, Petrov PD, Rey E, Marañón P, Del Pozo-Maroto E, Guzmán C et al (2018) Angiopoietin-like protein 8 is a novel vitamin D receptor target gene involved in nonalcoholic fatty liver pathogenesis. Am J Pathol 188(12):2800–2810
Gong Q, Ye L, Gui H, Liu J, Li H, Sun Q (2019) Association study of genetic variants of the ANGPTL3 gene and susceptibility to ischemic stroke. Neuropsychiatr Dis Treat 15:3015
González Rojo P, Pérez Ramírez C, Gálvez Navas JM, Pineda Lancheros LE, Rojo Tolosa S, Ramírez Tortosa MdC et al (2022) Vitamin D-related single nucleotide polymorphisms as risk biomarker of cardiovascular disease. Int J Mol Sci 23(15):8686
González-Molero I, Rojo-Martínez G, Morcillo S, Gutierrez C, Rubio E, Pérez-Valero V et al (2013) Hypovitaminosis D and incidence of obesity: a prospective study. Eur J Clin Nutr 67(6):680–682
Graham MJ, Lee RG, Brandt TA, Tai L-J, Fu W, Peralta R et al (2017) Cardiovascular and metabolic effects of ANGPTL3 antisense oligonucleotides. N Engl J Med 377:222–232
Judd S, Tangpricha V (2008) Vitamin D deficiency and risk for cardiovascular disease. Circulation 117(4):503
Kashkooli S, Choghakhori R, Hasanvand A, Abbasnezhad A (2019) Effect of calcium and vitamin D co-supplementation on lipid profile of overweight/obese subjects: a systematic review and meta-analysis of the randomized clinical trials. Obes Med 15:100124
Kasiske BL, Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ (1996) Cardiovascular disease after renal transplantation. J Am Soc Nephrol 7(1):158–165
Kilkkinen A, Knekt P, Aro A, Rissanen H, Marniemi J, Heliövaara M et al (2009) Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol 170(8):1032–1039
Laakso M (1999) Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 48(5):937–942
Li J, Byrne ME, Chang E, Jiang Y, Donkin SS, Buhman KK et al (2008) 1α, 25-Dihydroxyvitamin D hydroxylase in adipocytes. J Steroid Biochem Mol Biol 112(1–3):122–126
Li K, Kaaks R, Linseisen J, Rohrmann S (2012) Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Heidelberg). Heart 98(12):920–925
Li W-J, Yin R-X, Cao X-L, Chen W-X, Huang F, Wu J-Z (2018) DOCK7-ANGPTL3 SNPs and their haplotypes with serum lipid levels and the risk of coronary artery disease and ischemic stroke. Lipids Health Dis 17(1):30
Li Q, Dai Z, Cao Y, Wang L (2019) Association of C-reactive protein and vitamin D deficiency with cardiovascular disease: a nationwide cross-sectional study from national health and nutrition examination survey 2007 to 2008. Clin Cardiol 42(7):663–669
Lu X (2020) Structure and function of angiopoietin-like protein 3 (ANGPTL3) in atherosclerosis. Curr Med Chem 27(31):5159–5174
Luo M, Peng D (2018) ANGPTL8: an important regulator in metabolic disorders. Front Endocrinol 9:169
Luo M, Zhang Z, Peng Y, Wang S, Peng D (2018) The negative effect of ANGPTL8 on HDL-mediated cholesterol efflux capacity. Cardiovasc Diabetol 17(1):1–8
Minicocci I, Montali A, Robciuc MR, Quagliarini F, Censi V, Labbadia G et al (2012) Mutations in the ANGPTL3 gene and familial combined hypolipidemia: a clinical and biochemical characterization. J Clin Endocrinol Metab 97(7):E1266–E1275
Morelli MB, Chavez C, Santulli G (2020) Angiopoietin-like proteins as therapeutic targets for cardiovascular disease: focus on lipid disorders. Exp Opin Ther Targets 24(1):79–88
Morvaridzadeh M, Agah S, Alibakhshi P, Heydari H, Hoseini AS, Palmowski A et al (2021) Effects of calcium and vitamin d co-supplementation on the lipid profile: a systematic review and meta-analysis. Clin Ther 43(9):274–296
Musunuru K, Pirruccello JP, Do R, Peloso GM, Guiducci C, Sougnez C et al (2010) Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. N Engl J Med 363(23):2220–2227
Norman P, Powell J (2014) Vitamin D and cardiovascular disease. Circ Res 114(2):379–393
Nurmohamed N, Dallinga-Thie G, Stroes E (2020) Targeting apoC-III and ANGPTL3 in the treatment of hypertriglyceridemia. Exp Rev Cardiovasc Ther 18(6):355–361
Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ et al (2011) Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 305(11):1119–1127
Pilz S, Tomaschitz A, März W, Drechsler C, Ritz E, Zittermann A et al (2011) Vitamin D, cardiovascular disease and mortality. Clin Endocrinol 75(5):575–584
Pisciotta L, Favari E, Magnolo L, Simonelli S, Adorni MP, Sallo R et al (2012) Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3. Circ Cardiovasc Genet 5(1):42–50
Ponnana M, Sivangala R, Joshi L, Valluri V, Gaddam S (2017) IL-6 and IL-18 cytokine gene variants of pulmonary tuberculosis patients with co-morbid diabetes mellitus and their household contacts in Hyderabad. Gene 627:298–306
Reid IR, Birstow SM, Bolland MJ (2017) Calcium and cardiovascular disease. Endocrinol Metab 32(3):339–349
Robciuc MR, Maranghi M, Lahikainen A, Rader D, Bensadoun A, Öörni K et al (2013) Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids. Arterioscler Thromb Vasc Biol 33(7):1706–1713
Ruscica M, Zimetti F, Adorni MP, Sirtori CR, Lupo MG, Ferri N (2020) Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: new therapeutic approaches for the treatment of atherogenic dyslipidemia. Pharmacol Res 153:104653
Salehpour A, Shidfar F, Hosseinpanah F, Vafa M, Razaghi M, Hoshiarrad A et al (2012) Vitamin D 3 and the risk of CVD in overweight and obese women: a randomised controlled trial. Br J Nutr 108(10):1866–1873
Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR et al (2004) Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 141(6):421–431
Slinin Y, Foley RN, Collins AJ (2005) Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study. J Am Soc Nephrol 16(6):1788–1793
Sofianopoulou E, Kaptoge SK, Afzal S, Jiang T, Gill D, Gundersen TE et al (2021) Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses. Lancet Diabetes Endocrinol 9(12):837–846
Steinvil A, Leshem-Rubinow E, Berliner S, Justo D, Finn T, Ish-shalom M et al (2011) Vitamin D deficiency prevalence and cardiovascular risk in Israel. Eur J Clin Invest 41(3):263–268
Stitziel NO, Khera AV, Wang X, Bierhals AJ, Vourakis AC, Sperry AE et al (2017) ANGPTL3 deficiency and protection against coronary artery disease. J Am Coll Cardiol 69(16):2054–2063
Vanlint S (2013) Vitamin D and obesity. Nutrients 5(3):949–956
Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT et al (2013) Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 10(2):e1001383
Wang L, Manson JE, Song Y, Sesso HD (2010) Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med 152(5):315–323
Welty FK (2014) Hypobetalipoproteinemia and abetalipoproteinemia. Curr Opin Lipidol 25(3):161
Zhou A, Selvanayagam JB, Hyppönen E (2022) Non-linear Mendelian randomization analyses support a role for vitamin D deficiency in cardiovascular disease risk. Eur Heart J 43(18):1731–1739
Zittermann A, Schleithoff SS, Koerfer R (2005) Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 94(4):483–492
Funding
The authors have not disclosed any funding
Author information
Authors and Affiliations
Contributions
MA, MG, SG and PA-s: wrote the main manuscript text and MH, EB, TK and HE: prepared figures. AA, GAF, EM-M and MG-M: revised the manuscript. All authors reviewed the manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors have no conflict of interest to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Aghasizadeh, M., Ghanei, M., Ghoflchi, S. et al. Association of Genotypes of ANGPTL3 with Vitamin D and Calcium Concentration in Cardiovascular Disease. Biochem Genet (2023). https://doi.org/10.1007/s10528-023-10533-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10528-023-10533-3